Funding for this research was provided by:
Breast Cancer Now (.)
Cancer Research UK (.)
Text and Data Mining valid from 2019-06-14
Received: 5 December 2018
Accepted: 5 June 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: The protocol for the “NEO study: a study of factors predicting response to neoadjuvant chemotherapy in breast cancer” was approved by the South East Scotland Research Ethics Committee 01 with REC reference: 13/SS/0236. All patients signed an informed consent at least 24 h after receiving the patient information leaflet and after having the chance to discuss thoroughly their participation to this study either with treating clinician or research nurses.
: Not applicable
: All authors declare that they have no competing interests.